K863153

Substantially Equivalent

MODIFICATION OF CARDIOINTEGRAM/CARDIOINTEGRAPH

Applicant: Ocg Technology, Inc.
Product code: DXG
Advisory panel: Cardiovascular
Date received: 1986-08-15
Decision date: 1987-01-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Farmingdale, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.